| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/11/1996 | WO1996021000A2 Recombinant il-5 antagonists useful in treatment of il-5 mediated disorders |
| 07/11/1996 | WO1996020958A1 Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples |
| 07/11/1996 | WO1996020957A1 Anti-inflammatory cd14 polypeptides |
| 07/11/1996 | WO1996020955A1 Purified thrombopoietin and method of making it |
| 07/11/1996 | WO1996020951A1 Chimeric dna-binding proteins |
| 07/11/1996 | WO1996020948A1 Human pak65 |
| 07/11/1996 | WO1996020947A1 Method for the controlled synthesis of polynucleotide mixtures which encode desired mixtures of peptides |
| 07/11/1996 | WO1996020939A1 POLYMORPHS B AND C OF 1-[2,4-DICHLORO-β-[(7-CHLOROBENZO[b]THIEN-3-YL)METHOXY]PHENETYL]IMIDAZOLE MONONITRATE |
| 07/11/1996 | WO1996020733A1 Treatment of tumors by transduction with negative selective markers, application of interaction agents and subsequent radiation exposure |
| 07/11/1996 | WO1996020732A2 Non-traumatic administration of gene delivery vehicles |
| 07/11/1996 | WO1996020731A1 Direct administration of gene delivery vehicles at multiple sites |
| 07/11/1996 | WO1996020724A1 Generation of human insulin |
| 07/11/1996 | WO1996020723A1 Controlling traf-mediated signals |
| 07/11/1996 | WO1996020721A1 Programmed cell death genes and proteins |
| 07/11/1996 | WO1996020688A2 Triggered pore-forming agents |
| 07/11/1996 | WO1996020598A1 Gene transduction system |
| 07/11/1996 | WO1996020596A1 Use of flavonoid aldehydes as pesticides |
| 07/11/1996 | WO1996020595A1 Modulating toxic metabolite levels in consumable products |
| 07/11/1996 | WO1996020594A1 Use of flavonoid aldehydes as insecticides |
| 07/11/1996 | WO1996020286A1 Automated dna sequencing |
| 07/11/1996 | WO1996015758A3 Methods for stimulating erythropoiesis using thrombopoietin |
| 07/11/1996 | WO1996013612A3 Compositions and methods for the simultaneous detection and quantification of multiple specific nucleic acid sequences |
| 07/11/1996 | WO1996013608A3 Polynucleic acid sequences for use in the detection and differentiation of prokaryotic organisms |
| 07/11/1996 | WO1996010635A3 Genes encoding signal recognition particle of aspergillus niger |
| 07/11/1996 | WO1996008565A3 RECOMBINANT PEPTIDES DERIVED FROM THE Mc3 ANTI-BA46 ANTIBODY, METHODS OF USE THEREOF, AND METHODS OF HUMANIZING ANTIBODY PEPTIDES |
| 07/11/1996 | WO1996007745A3 Mycobacteria functional screening and/or expression vectors |
| 07/11/1996 | CA2209526A1 Programmed cell death genes and proteins |
| 07/11/1996 | CA2209523A1 Quantitative detection of specific nucleic acid sequences using lambdoid bacteriophages linked by oligonucleotides to solid support |
| 07/11/1996 | CA2209226A1 Polymerase .delta. mutations in colorectal tumors with replication errors |
| 07/11/1996 | CA2209183A1 Chimeric dna-binding proteins |
| 07/11/1996 | CA2209098A1 Gene transduction system |
| 07/11/1996 | CA2208760A1 Use of aromatic aldehydes as insecticides |
| 07/11/1996 | CA2208755A1 Use of aromatic aldehydes as pesticides |
| 07/11/1996 | CA2208753A1 Modulating toxic metabolite levels in consumable products |
| 07/11/1996 | CA2208699A1 Anti-inflammatory cd14 polypeptides |
| 07/11/1996 | CA2208693A1 Method for the controlled synthesis of polynucleotide mixtures which encode desired mixtures of peptides |
| 07/11/1996 | CA2208411A1 Monoclonal antibodies specific for advanced glycosylation endproducts in biological samples |
| 07/11/1996 | CA2208107A1 Isolated dna encoding enzyme for phage resistance |
| 07/11/1996 | CA2207974A1 Treatment of tumors by transduction with negative selective markers, application of interaction agents and subsequent radiation exposure |
| 07/11/1996 | CA2207577A1 Purified thrombopoietin and method of making it |
| 07/11/1996 | CA2206479A1 New staphylokinase derivatives |
| 07/11/1996 | CA2205871A1 Borna disease viral sequences, diagnostics and therapeutics for nervous system diseases |
| 07/10/1996 | EP0721016A2 Nucleic acid library arrays, methods for synthesizing them and methods for sequencing and sample screening using them |
| 07/10/1996 | EP0721015A1 Monoclonal antibody that induces apoptosis |
| 07/10/1996 | EP0721014A1 Monoclonal antibody that recognizes interstitial cell surface antigen |
| 07/10/1996 | EP0721013A1 New staphylokinase derivatives |
| 07/10/1996 | EP0721012A2 Hyaluronic acid mediated motility receptor (RHAMM) |
| 07/10/1996 | EP0720659A1 Nucleic acid detection with energy transfer |
| 07/10/1996 | EP0720654A1 Novel proteins/polypeptides and cotransfection plasmids and live recombinant carriers therefor |
| 07/10/1996 | EP0720653A1 Tbp2 FRAGMENTS OF THE TRANSFERRINE RECEPTOR OF NEISSERIA MENINGITIDIS |
| 07/10/1996 | EP0720652A1 Receptor recognition factors, protein sequences and methods of use thereof |
| 07/10/1996 | EP0720651A1 Nucleic acids encoding merosin, merosin fragments and uses thereof |
| 07/10/1996 | EP0720650A1 Human metabotropic glutamate receptor subtypes (hmr4, hmr6, hmr7) and related dna compounds |
| 07/10/1996 | EP0720624A1 Retargeting antibodies |
| 07/10/1996 | EP0720484A1 Methods and products for controlling immune responses in mammals |
| 07/10/1996 | EP0666929A4 Method of inhibiting replication of hyperproliferative cells. |
| 07/10/1996 | EP0403506B1 Method of screening for protein inhibitors and activators |
| 07/10/1996 | CN1126496A Method for detection of susceptibility mutations for ototoxic deafness |
| 07/10/1996 | CN1126494A Method for recombinant production of biologically active polypeptides |
| 07/10/1996 | CN1126492A Recombinant antigens from mumps virus and their use in vaccines |
| 07/10/1996 | CN1126491A Intracellular binding proteins and use thereof |
| 07/10/1996 | CN1126489A New stromal cell lines from human bone marrow and their use |
| 07/10/1996 | CN1126423A Method of controlling insects |
| 07/10/1996 | CN1126243A Heat tolerant phytases |
| 07/09/1996 | US5534660 Ph genes and their uses |
| 07/09/1996 | US5534617 Human growth hormone variants having greater affinity for human growth hormone receptor at site 1 |
| 07/09/1996 | US5534439 Isolated DNA of human papillomavirus type 55 (HPV55) |
| 07/09/1996 | US5534432 Polyhydroxybutyrate polymerase |
| 07/09/1996 | US5534431 Hybridomas and monoclonal antibodies specific for unique determinants of nephropathy-related immunoglobulin G and complexes thereof |
| 07/09/1996 | US5534428 Cloned Ssti/SacI restriction-modification system |
| 07/09/1996 | US5534427 Gene expression |
| 07/09/1996 | US5534426 Oncoprotein protein kinase |
| 07/09/1996 | US5534424 Chemical method for the analysis of DNA sequences |
| 07/09/1996 | US5534423 Methods of increasing rates of infection by directing motion of vectors |
| 07/09/1996 | US5534419 Method of producing foreign gene products |
| 07/09/1996 | US5534418 Controlled expression of recombinant proteins |
| 07/09/1996 | US5534411 Monoclonal IgA antibody specific for respiratory syncytial virus, a hybridoma cell line that produces this antibody amd methods of using the antibody to diagnose RSV infection |
| 07/09/1996 | US5534410 TATA-binding protein associated factors drug screens |
| 07/09/1996 | US5534405 Antibodies, diagnostic systems and methods for assaying HBxAg |
| 07/09/1996 | US5534257 Genetic engineering; insertion of foreign peptide epitope; vaccines |
| 07/09/1996 | US5534254 Biosynthetic binding proteins for immuno-targeting |
| 07/09/1996 | US5534223 Immunoenzymological assay for proteins using alkaline phosphatase joined to polypeptides and interacting with antigens or antibodies |
| 07/09/1996 | US5534054 Silicon tetrahydrazide for purification of DNA |
| 07/09/1996 | CA2050468C A thermostable (1,3-1,4)-.beta.-glucanase |
| 07/09/1996 | CA1338441C Expression of immunologically active proteins of human .beta.-lympho tropic virus |
| 07/09/1996 | CA1338440C Process for the isolation and characterisation of a gene enzyme system for inactivation of the herbicide phenmedipham |
| 07/07/1996 | WO1996015261A3 Nucleotide sequences hybridizing specifically with a genomic nucleic sequence of campylobacter |
| 07/04/1996 | WO1996020403A1 Assay, receptor proteins and ligands |
| 07/04/1996 | WO1996020289A1 Nucleic acid sequence detection employing amplification probes |
| 07/04/1996 | WO1996020281A1 Human phosphodiesterase type ivc, and its production and use |
| 07/04/1996 | WO1996020280A1 Isolated polysialyl transferases, nucleic acid molecules coding therefor, methods of production and use |
| 07/04/1996 | WO1996020279A1 Method and reagent for prevention, inhibition of progression and regression of vascular diseases |
| 07/04/1996 | WO1996020278A2 Genetically engineered human-derived kunitz domains that inhibit human neutrophil elastase |
| 07/04/1996 | WO1996020277A2 Recombinant monoclonal anti-idiotype antibody 3h1 sequences relating to human carcinoembryonic antigen |
| 07/04/1996 | WO1996020273A1 Human immunodeficiency virus vaccines and therapeutics containing replication-impaired hiv-1 nef-deletion mutants |
| 07/04/1996 | WO1996020219A2 Murine monoclonal anti-idiotype antibody 3h1 |
| 07/04/1996 | WO1996020217A1 Monoclonal antibody |
| 07/04/1996 | WO1996020214A1 Tcf mutant |
| 07/04/1996 | WO1996020213A1 Recombinant antigen for diagnosing rheumatoid arthritis |
| 07/04/1996 | WO1996020207A1 MUTANTS OF THE Rb AND p53 GENES AND USES THEREOF |